MRS and MRI of Brain Degeneration and Disorders

Room A108
10:30 – 12:30

Chairs: Dorothee P. Auer and Brian D. Ross

10:30   290.  Volumes of Entorhinal Cortex and Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease, A.T. Du, N. Schuff, D. Amend, Y.Y. Hsu, M.P. Laakso, K. Yaffe and M.W. Weiner, DVA Medical Center, University of California, San Francisco, CA, USA; Chang Gung Memorial Hospital, Taiwan and University of Kuopio, Kuopio, Finland.
10:42   291.  Entorhinal Cortex Volume Asymmetry May Signal Higher Risk for Alzheimer's Disease, F.M. Lalonde, M. Myslobodsky, C. Small, F. Gwadry and T. Sunderland, National Institutes of Health, Bethesda, MD, USA.
10:54   292.  Differentiating Alzheimer's Diseases Using Artificial Neural Network Analysis of In Vivo Proton Spectroscopy, B.S. Qiu, W.M. An, Q. Tong, Y.G. Gao, Y.Q. Cai, L.Q. Cheng, X. Ma and J-M. Zhu, PLA General Hospital, Beijing, China; GE Medical Systems, Beijing, China and GE Medical Systems, Milwaukee, WI, USA.
11:06   293.  Longitudinal Decline of NA in Alzheimer's Disease, E. Adalsteinsson, E.V. Sullivan, N. Kleinhans, D.M. Spielman and A. Pfefferbaum, Stanford University, Stanford, CA, USA and SRI International, Menlo Park, CA, USA.
11:14   294.  Hippocampal NAA Differences Despite Similar Atrophy Between Subcortical Ischemic Vascular Dementia and Alzheimer's Disease, N. Schuff, A.T. Du, T. Greenfield, D. Amend, D. Norman, H. Chui and M.W. Weiner, DVA Medical Center and University of California, San Francisco CA, USA and University of Southern California, Los Angeles, CA, USA.
11:30   295.  Vascular Dementia: Non-Invasive Assay of Pathologic Neurochemistry and Improved Diagnosis Using Proton NMR Spectroscopy (¹H MRS), S. Herminghaus, C. Gorriz, U. Pilatus, H. Lanfermann, L. Frölich and F.E. Zanella, University of Frankfurt/Main, Frankfurt, Germany.
11:42   296.  Cognitive Dysfunction Lateralizes with NAA in Multiple Sclerosis, J.W. Pan, L.B. Krupp, L. Elkins and P.K. Coyle, Brookhaven National Laboratory, Upton, NY, USA and State University of New York, Stony Brook, NY, USA.
11:54   297.  Disease Duration Influences the Relationship Between Brain Axonal Injury, Spinal Cord Atrophy and Disability in Multiple Sclerosis, S. Narayanan, N. De Stefano, S. Francis, M.C. Tartaglia, R. Arnaoutelis and D.L. Arnold, Montreal Neurological Institute, Montreal, Quebec, Canada and University of Siena, Siena, Italy.
12:06   298.  ¹³C MRS Further Specifies Biochemical Abnormalities Detected by ¹H MRS in Human Brain, S. Blüml, A. Moreno, J-H. Hwang and B.D. Ross, Huntington Medical Research Institutes, Pasadena, CA, USA and Rudi Schulte Research Institutes, Santa Barbara, CA, USA.
12:18   299.  Recommendations for Brain Phenylalanine Levels in Adult Individuals with Phenylketonuria, R.A. Moats, A. Stern, R. Koch and M.D. Nelson, Jr., Childrens Hospital Los Angeles, Los Angeles, CA, USA.

Return to ISMRM program